Higher daily step counts are associated with fewer depressive symptoms in adults, according to a systematic review.

Neumora's depression drug fails Phase 3, Pfizer exits Sangamo hemophilia A gene therapy partnership, and biotech sees surge in megarounds with 96 nine-figure financings in 2024.

Neumora Therapeutics announced that its antidepressant candidate, navacaprant, did not meet the primary endpoint in a Phase 3 study for major depressive disorder.

Even the coroner specified that the self-inflicted death was an “adverse effect” of the antidepressant the man had been ...

People explore different treatments and therapies to help with depression, and recently, researchers wanted to understand if ...

If you ever wonder why our lives seem so out of control, perhaps the answer is that we are merely pieces on a Cosmic Game Board.

Investing during a period of economic depression or recession can be daunting. However, choosing the right depression stocks can help you weather a period of uncertainty and protect your financial ...

Growing brain research reveals the habenula's outsize impact on our health, from mood and anxiety to addiction and sleep.

Dec. 17, 2024 — Almost three quarters of adolescents in Australia experience clinically significant depression or anxiety symptoms, with most being chronic, according to a new study. And ...

They found that taking 7000 steps a day reduced the likelihood of depression by 31 per cent. The risk also decreased by a further nine per cent for every 10,000 steps a day, the study published in the ...

This article reviews the contribution of recent preclinical, clinical and pharmacogenetic literature to current knowledge on the short-term and enduring neural effects of antidepressants on the ...

Wisconsin Public Radio When Dr. Norman Rosenthal lived in South Africa, he began to notice changes in his health as the days got ...